10
Participants
Start Date
November 1, 2025
Primary Completion Date
November 1, 2027
Study Completion Date
November 1, 2028
Nelitolimod
Nelitolimod drug product is a clear to slightly opalescent, colorless to pale yellow solution free of visible particles and is supplied by TriSalus to the study sites in single-use vials. One vial is to be used per patient, and each vial should be discarded immediately after use.
RJ Zuckerberg, Lake Success
Lead Sponsor
Northwell Health
OTHER